Valero, Sergi

New insights into the genetic etiology of Alzheimer’s disease and related dementias

Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 2,498

Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder

Corominas-Roso, M., Ramos-Quiroga, J. A., Ribases, M., Sanchez-Mora, C., Palomar, G., Valero, S., Bosch, R., & Casas, M. (2013) · International Journal of Neuropsychopharmacology

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 80

Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease

DeMichele-Sweet, M. A. A., Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernandez, I., Moreno-Grau, S., Tárraga, L., et al. (2021) · Molecular Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 64

PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

(ADNI), A. D. N. I., Kleineidam, L., Chouraki, V., Próchnicki, T., van der Lee, S. J., Madrid-Márquez, L., Wagner-Thelen, H., Karaca, I., Weinhold, L., Wolfsgruber, S., et al. (2020) · Acta Neuropathologica

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 62

Effect of Switching Drug Formulations from Immediate-Release to Extended-Release OROS Methylphenidate: A Chart Review of Spanish Adults with Attention-Deficit Hyperactivity Disorder

Ramos-Quiroga, J. A., Bosch, R., Castells, X., Valero, S., Nogueira, M., Gómez, N., Yelmo, S., Ferrer, M., Martínez, Y., & Casas, M. (2008) · CNS Drugs

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 54

Attention deficit hyperactivity disorder in cocaine‐dependent adults: A psychiatric comorbidity analysis

Daigre, C., Roncero, C., Grau‐López, L., Martínez‐Luna, N., Prat, G., Valero, S., Tejedor, R., Ramos‐Quiroga, J. A., & Casas, M. (2013) · The American Journal on Addictions

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 52

Predicting treatment failure in pathological gambling: The role of personality traits

Ramos-Grille, I., Gomà-i-Freixanet, M., Aragay, N., Valero, S., & Vallès, V. (2015) · Addictive Behaviors

Gambling Behavior and TreatmentsPersonality Disorders and Psychopathology

Cited by 52

Risk factors for cocaine-induced psychosis in cocaine-dependent patients

Roncero, C., Daigre, C., Gonzalvo, B., Valero, S., Castells, X., Grau-López, L., Eiroa-Orosa, F. J., & Casas, M. (2013) · European Psychiatry

Substance Abuse Treatment and OutcomesSchizophrenia research and treatment

Cited by 48

Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer’s type

Martino Adami, P. V., Orellana, A., García, P., Kleineidam, L., Alarcón-Martín, E., Montrreal, L., Aguilera, N., Espinosa, A., Abdelnour, C., Rosende-Roca, M., et al. (2022) · Brain

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 46

A satisfaction survey of opioid-dependent clients at methadone treatment centres in Spain

Pérez de los Cobos, J., Fidel, G., Escuder, G., Haro, G., Sánchez, N., Pascual, C., Carlos Valderrama, J., Valero, S., & Trujols, J. (2004) · Drug and Alcohol Dependence

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 40

Emotional lability: The discriminative value in the diagnosis of attention deficit/hyperactivity disorder in adults

Vidal, R., Valero, S., Nogueira, M., Palomar, G., Corrales, M., Richarte, V., Bosch, R., Gómez-Barros, N., Corominas, M., Casas, M., et al. (2014) · Comprehensive Psychiatry

Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research

Cited by 36

Common variants in Alzheimer’s disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores

de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I., Pedersen, N. L., Stringa, N., Zettergren, A., Hernández, I., et al. (2019) · medRxiv

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 28

Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias

EADB, Bellenguez, C., Castillo Morales, A., Amin, N., van der Lee, S. J., Muntaner, M., Parveen, K., Küçükali, F., Grenier-Boley, B., Heikkinen, S., et al. (2026) · Nature Genetics

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 7

Serum proteomics reveals APOE dependent and independent protein signatures in Alzheimer’s disease

Frick, E. A., Emilsson, V., Jonmundsson, T., Steindorsdottir, A. E., Johnson, E. C. B., Puerta, R., Dammer, E. B., Shantaraman, A., Cano, A., Boada, M., et al. (2023) · medRxiv

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 3

Federated learning for cognitive impairment detection using speech data

Blazquez-Folch, J., Limones Andrade, M., Calm, B., Auñón García, J. M., Alegret, M., Muñoz, N., Cano, A., Fernández, V., García-Gutiérrez, F., De Rojas, I., et al. (2025) · Frontiers in Artificial Intelligence

Privacy-Preserving Technologies in DataDementia and Cognitive Impairment Research

Cited by 2